CULLINAN ONCOLOGY INC's ticker is CGEM and the CUSIP is 230031106. A total of 89 filers reported holding CULLINAN ONCOLOGY INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $76,056 | -23.5% | 8,404 | -9.0% | 0.05% | -22.0% |
| Q2 2023 | $99,412 | +14.6% | 9,239 | +8.9% | 0.06% | +22.9% |
| Q1 2023 | $86,781 | -30.0% | 8,483 | -27.8% | 0.05% | -26.2% |
| Q4 2022 | $123,973 | +11.7% | 11,751 | +35.3% | 0.06% | +47.7% |
| Q3 2022 | $111,000 | 0.0% | 8,686 | +0.8% | 0.04% | +7.3% |
| Q2 2022 | $111,000 | +6.7% | 8,620 | -13.3% | 0.04% | -12.8% |
| Q1 2022 | $104,000 | -36.2% | 9,941 | -5.6% | 0.05% | -24.2% |
| Q4 2021 | $163,000 | +4.5% | 10,536 | +52.1% | 0.06% | -10.1% |
| Q3 2021 | $156,000 | -16.6% | 6,925 | -4.9% | 0.07% | -10.4% |
| Q2 2021 | $187,000 | – | 7,281 | – | 0.08% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| MPM BioImpact LLC | 7,648,268 | $98,051,000 | 27.24% |
| CHI Advisors LLC | 3,047,609 | $39,070,000 | 14.92% |
| Nextech Invest Ltd. | 1,221,145 | $15,655,000 | 5.28% |
| BVF INC/IL | 7,509,059 | $96,266,000 | 4.65% |
| TANG CAPITAL MANAGEMENT LLC | 609,231 | $7,810,000 | 1.18% |
| Boxer Capital, LLC | 1,074,082 | $13,770,000 | 0.87% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 213,090 | $2,732,000 | 0.84% |
| Atom Investors LP | 96,880 | $1,242,000 | 0.54% |
| EcoR1 Capital, LLC | 1,169,889 | $14,998,000 | 0.52% |
| Birchview Capital, LP | 45,114 | $578,000 | 0.42% |